Case Report: First report of spinal stenosis in Imagawa-Matsumoto syndrome: a novel SUZ12 variant in an 11-year-old Chinese child
Frontiers in Genetics · 14.07.2026 · 17
DOI: 10.3389/fgene.2026.1867197 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Genetics, online erschienen am 14.07.2026. Verfasst von Zixi Pang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To expand the phenotypic and genotypic spectrum of Imagawa-Matsumoto syndrome (IMMAS) by investigating the genetic etiology and unique clinical manifestations of an overgrowth case associated with a SUZ12 gene variant.
Methods
We report a case of IMMAS in an 11-year-old Chinese girl who was admitted to our hospital due to unsteady gait and an abnormal walking pattern for 1.5 years. Trio-based whole-exome sequencing (trio-WES) was performed to identify the genetic etiology. Additionally, we conducted a systematic literature review of previously reported cases of overgrowth syndromes associated with SUZ12 variants.
Results
The patient presented with generalized overgrowth, characteristic facial features, and skeletal abnormalities consistent with IMMAS. Cervical spine magnetic resonance imaging (MRI) revealed cervical canal stenosis accompanied by signs of cervical spinal cord compression and cord edema. The patient underwent posterior cervical single-door decompression, canal expansion with internal fixation, and adhesiolysis of the spinal cord and nerve roots. Trio-WES identified a de novo variant in SUZ12 (NM_015355.4, c.1783_1786del; p. Lys595Profs*18). The literature review suggested that cervical spinal stenosis in our case may represent a newly reported phenotype associated with SUZ12 variants.
Conclusion
Our findings expand the phenotypic and genotypic spectrum of IMMAS. For patients with overgrowth syndromes, spinal stenosis should be considered during clinical evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Research Unit, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
- Department of Orthopaedics, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
- Molecular Medical Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
- Department of Radiology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
- Department of Clinical Immunology and Allergy, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Zitieren
APA
Pang, Z., Zhang, T., Wang, D., Xu, P., Wu, B., Shen, Q., & Hou, J. (2026). Case Report: First report of spinal stenosis in Imagawa-Matsumoto syndrome: a novel SUZ12 variant in an 11-year-old Chinese child. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1867197
Vancouver
Pang Z, Zhang T, Wang D, Xu P, Wu B, Shen Q, et al. Case Report: First report of spinal stenosis in Imagawa-Matsumoto syndrome: a novel SUZ12 variant in an 11-year-old Chinese child. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1867197
BibTeX
@article{Pang2026,
author = {Pang, Zixi and Zhang, Tao and Wang, Dahui and Xu, Ping and Wu, Bingbing and Shen, Quanli and Hou, Jia},
title = {Case Report: First report of spinal stenosis in Imagawa-Matsumoto syndrome: a novel SUZ12 variant in an 11-year-old Chinese child},
journal = {Frontiers in Genetics},
year = {2026},
volume = {17},
doi = {10.3389/fgene.2026.1867197}
}
EUVIMED